CeriBell, Inc. (CBLL) Fair Value 2026

CBLL · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.1 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (25/100)

Quick Summary — As of 2026-08-27, CeriBell, Inc. (CBLL) trades at $23.37. QOC: 6.1/10. Value Trap Risk: 25/100 (LOW). 0/13 models active.

Key Facts

Ticker
CBLL
Price
$23.37
Quality Score
6.1/10
Value Trap Risk
25/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give CBLL?

0 Intrinsic Value Models vs. Current Price ($23.37)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is CeriBell, Inc. (CBLL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, CeriBell, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About CBLL?

0 of 13 models are currently active for CBLL. See which stocks rank higher →

How Does CBLL Rank in Medical Devices?

Among 157 Medical Devices stocks, CBLL ranks #84 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

As a pharmaceutical industry, CeriBell, Inc. operates in a sector where R&D productivity ratio is a critical driver of valuation. Investors evaluating CBLL should weigh these sector-specific dynamics alongside our model-derived fair values.

Is CBLL a Value Trap?

CirclFi's Value Trap algorithm assigns CBLL a score of 25/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for CeriBell, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, CeriBell, Inc.'s fundamental quality profile registers 6.1/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CBLL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy CeriBell, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

AVRAnteris Technologies Global Corp.QOC 6.1BBNXBeta Bionics, Inc.QOC 6.1OMOutset Medical, Inc.QOC 6.1ENOVEnovis CorporationQOC 6.1NSPRInspireMD, Inc.QOC 6.1RPIDRapid Micro Biosystems, Inc.QOC 6.1VTAKCatheter Precision, Inc.QOC 5.0UFPTUFP Technologies, Inc.QOC 9.2KIDSOrthoPediatrics Corp.QOC 7.1IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: AVR · BBNX · OM · ENOV · NSPR · RPID · VTAK · UFPT · KIDS · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to CBLL?

6 companies across all industries closest to CBLL’s Quality of Company score of 6.1/10.

MANUManchesterQOC 6.1POCIPrecision Optics Corporation, Inc.QOC 6.1GLUEMonte Rosa Therapeutics, Inc.QOC 6.1NAVNNavan, Inc.QOC 6.1JZJianzhi Education Technology Group Company LimitedQOC 6.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: MANU · POCI · GLUE · NAVN · JZ · NVDA

Where Does CBLL Sit in CirclFi's Medical Devices Rankings?

CBLL is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About CeriBell, Inc.’s Valuation?

What is CeriBell, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for CeriBell, Inc. (CBLL). The Quality of Company score is 6.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CBLL overvalued or undervalued right now?

At $23.37, 0 of 0 active models suggest CBLL may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits CeriBell, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 6.1 mean for CBLL?

CeriBell, Inc.'s QOC of 6.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on CBLL?

CirclFi analyzes CBLL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is CBLL a value trap in 2026?

CeriBell, Inc.'s Value Trap score is 25/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns CeriBell, Inc. (CBLL) a Quality of Company score of 6.1/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/CBLL/ · Methodology
Primary sources for this CBLL valuation
  • Financial statements: CeriBell, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001861107) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CBLL as of ; valuations recomputed .